Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113307778A reveals a novel Mo/Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering cost reduction in API manufacturing and scalable production.
Patent CN105061325A details aqueous Pd/C catalysis for high-purity biaryl benzimidazole intermediates ensuring supply chain stability and significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN113603639A reveals a cost-effective nucleophilic substitution method for 2-cyano-5-bromopyridine, offering superior purity and yield for pharmaceutical supply chains.
Patent CN118619879A reveals a novel Rh-catalyzed method for trifluoromethyl enaminones. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable processes.
Novel palladium-catalyzed route for 6-H-phenanthridine compounds ensures high yield and scalable production for global pharmaceutical supply chains and cost efficiency.
Patent CN113461589B details a novel one-step asymmetric Friedel-Crafts reaction for chiral 2,3-disubstituted indoleamines, offering significant cost reduction in API manufacturing.
Patent CN110105319A details iron-catalyzed C-3 alkylation. Offers green, scalable route for pharmaceutical intermediates with cost advantages.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of key heterocyclic building blocks.
Novel chiral phosphoric acid catalyzed synthesis of indoxazinones with high enantioselectivity and mild conditions for anticancer drug development.
Patent CN107936025B details a metal-free NHC catalytic route for high-purity chiral intermediates, offering significant cost reduction in API manufacturing and scalable supply.
Patent CN111978265B reveals a novel FeCl3-catalyzed route for 5-trifluoromethyl-1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production.
Novel trifluoromethanesulfonic acid catalyzed process ensures high purity 4,4'-dihydroxybenzophenone with reduced environmental impact and scalable manufacturing capabilities for global supply chains.
Patent CN114160206B reveals a novel chiral copper catalyst for optically active indoles. Achieve >91% ee and substantial cost reduction in API manufacturing with scalable processes.
Novel palladium-catalyzed carbonylation using formic acid ensures safe scalable production of high-purity indene derivatives for global supply chains.
Patent CN118878452B reveals a mild catalytic route for anti-tumor intermediates. This report analyzes supply chain stability and cost reduction in pharma manufacturing.
Novel synthesis route for Orforglipron intermediate reduces waste and cost. Reliable supply chain for GLP-1 drug precursors.
Patent CN102153433B details an aerobic oxidative synthesis of N-monosubstituted-alpha-carbonylamides. This method offers significant cost reduction in pharmaceutical intermediate manufacturing via mild, scalable conditions.
Novel sulfur-mediated synthesis offers cost-effective scalable production for high-purity pharmaceutical intermediates without heavy metals ensuring supply chain reliability.
Patent CN114195711B reveals a novel Pd-catalyzed carbonylation route for quinoline-4(1H)-ones, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN113735778B reveals efficient silver oxide promoted route. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.